Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Saipu Ruisi Pharmaceutical Technology is a China-based pharmaceutical technology company that operates as a contract research and manufacturing organization (CRO/CDMO). Founded in 2016 and headquartered in Shijiazhuang, the company specializes in the custom synthesis and production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Their core competencies lie in small molecule chemistry, offering services that range from laboratory-scale R&D to pilot and commercial-scale manufacturing. Saipu Ruisi serves a global clientele in the biotech and pharmaceutical sectors, providing technical support for drug discovery and process optimization. The company maintains modern facilities designed to meet international quality standards for chemical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Saipu Ruisi Pharmaceutical Technology.